Zobrazeno 1 - 4
of 4
pro vyhledávání: '"María Antonia González-Zavala"'
Autor:
María Antonia González-Zavala, Celia N Sánchez-Domínguez, Clara Patricia Rios-Ibarra, Jesús Morlett-Chávez, Lilia Carranza-González, Ana Cecilia Cepeda-Nieto, Rafael B. R. León-Cachón, Mauricio Salinas-Santander
Publikováno v:
Archives of Medical Research. 49:94-100
Obesity is a complex, chronic, and multifactorial disease that has become a major, and worldwide, public health problem contributing to an increased number of pathologies, including type 2 diabetes, cardiovascular disease, hyperlipidemia, and metabol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6229ce587a094d9172de17e33498e6
https://doi.org/10.1016/j.arcmed.2018.04.013
https://doi.org/10.1016/j.arcmed.2018.04.013
Autor:
María Antonia González-Zavala, Celia Nohemí Sánchez‑Domínguez, Hugo Leonid Gallardo‑Blanco, Miguel Ángel González-Madrazo, Sandra Cecilia Esparza González, Ana Cecilia Cepeda Nieto, Mauricio Andres Salinas‑Santander, Rafael Baltazar Reyes León‑Cachón
Publikováno v:
Biomedical Reports. 4:107-111
Obesity is currently considered an inflammatory condition associated with autoimmune diseases, suggesting a common origin. Among other factors, candidate genes may explain the development of this disease. Polymorphisms in the tumor necrosis factor α
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9074cb6ac07451a60583ba8d1c473ed6
https://doi.org/10.3892/br.2015.534
https://doi.org/10.3892/br.2015.534
Autor:
J.J. Terrazas-Flores, María Antonia González-Zavala, M.G. de la Cruz-Galicia, A. Velasco-Morales, A. Hernández-del Río, Ana Cecilia Cepeda-Nieto
Publikováno v:
Medicina Universitaria. 17:80-87
IntroductionAn alarming rise of obesity in adolescents has been observed, placing them at risk of developing resistance to insulin (IR) and its adverse metabolic consequences such as diabetes mellitus type 2 (DM2), metabolic syndrome and cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1533af282bc790197b819f806017783e
https://doi.org/10.1016/j.rmu.2015.02.004
https://doi.org/10.1016/j.rmu.2015.02.004
Autor:
Yesenia Silva-Belmares, María Antonia González-Zavala, Luis E. Cobos-Puc, David Centurión, Hilda Aguayo-Morales
Publikováno v:
European journal of pharmacology. 782
Moxonidine centrally inhibits the sympathetic activity through the I1-imidazoline receptor and nitric oxide. In addition, inhibits the peripheral cardiac sympathetic outflow by α2-adrenoceptors/I1-imidazoline receptors, although the role of α2-adre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2225fd5c1374a9e626b72d70c47d5de6
https://pubmed.ncbi.nlm.nih.gov/27112661
https://pubmed.ncbi.nlm.nih.gov/27112661